These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 19091749)
1. Methylalpinumisoflavone inhibits hypoxia-inducible factor-1 (HIF-1) activation by simultaneously targeting multiple pathways. Liu Y; Veena CK; Morgan JB; Mohammed KA; Jekabsons MB; Nagle DG; Zhou YD J Biol Chem; 2009 Feb; 284(9):5859-68. PubMed ID: 19091749 [TBL] [Abstract][Full Text] [Related]
2. Pseudolaric acid B inhibits angiogenesis and reduces hypoxia-inducible factor 1alpha by promoting proteasome-mediated degradation. Li MH; Miao ZH; Tan WF; Yue JM; Zhang C; Lin LP; Zhang XW; Ding J Clin Cancer Res; 2004 Dec; 10(24):8266-74. PubMed ID: 15623602 [TBL] [Abstract][Full Text] [Related]
3. Identification of novel antiangiogenic anticancer activities of deguelin targeting hypoxia-inducible factor-1 alpha. Oh SH; Woo JK; Jin Q; Kang HJ; Jeong JW; Kim KW; Hong WK; Lee HY Int J Cancer; 2008 Jan; 122(1):5-14. PubMed ID: 17764071 [TBL] [Abstract][Full Text] [Related]
4. A novel inhibitor of hypoxia-inducible factor-1α P3155 also modulates PI3K pathway and inhibits growth of prostate cancer cells. Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Sonawane V; Rathos MJ; Kumar S; Joshi KS BMC Cancer; 2011 Aug; 11():338. PubMed ID: 21819554 [TBL] [Abstract][Full Text] [Related]
5. Silver nanoparticles inhibit the function of hypoxia-inducible factor-1 and target genes: insight into the cytotoxicity and antiangiogenesis. Yang T; Yao Q; Cao F; Liu Q; Liu B; Wang XH Int J Nanomedicine; 2016; 11():6679-6692. PubMed ID: 27994464 [TBL] [Abstract][Full Text] [Related]
6. Hydrogen sulfide inhibits hypoxia- but not anoxia-induced hypoxia-inducible factor 1 activation in a von hippel-lindau- and mitochondria-dependent manner. Kai S; Tanaka T; Daijo H; Harada H; Kishimoto S; Suzuki K; Takabuchi S; Takenaga K; Fukuda K; Hirota K Antioxid Redox Signal; 2012 Feb; 16(3):203-16. PubMed ID: 22004513 [TBL] [Abstract][Full Text] [Related]
7. Rhapontigenin inhibited hypoxia inducible factor 1 alpha accumulation and angiogenesis in hypoxic PC-3 prostate cancer cells. Jung DB; Lee HJ; Jeong SJ; Lee HJ; Lee EO; Kim YC; Ahn KS; Chen CY; Kim SH Biol Pharm Bull; 2011; 34(6):850-5. PubMed ID: 21628883 [TBL] [Abstract][Full Text] [Related]
8. Anti-angiogenic effects of ribonucleic acid interference targeting vascular endothelial growth factor and hypoxia-inducible factor-1alpha. Forooghian F; Das B Am J Ophthalmol; 2007 Nov; 144(5):761-8. PubMed ID: 17869204 [TBL] [Abstract][Full Text] [Related]
9. Hypoxia effects on proangiogenic factors in human umbilical vein endothelial cells: functional role of the peptide somatostatin. Dal Monte M; Martini D; Ristori C; Azara D; Armani C; Balbarini A; Bagnoli P Naunyn Schmiedebergs Arch Pharmacol; 2011 Jun; 383(6):593-612. PubMed ID: 21523559 [TBL] [Abstract][Full Text] [Related]
10. Molecular-targeted antitumor agents. 19. Furospongolide from a marine Lendenfeldia sp. sponge inhibits hypoxia-inducible factor-1 activation in breast tumor cells. Liu Y; Liu R; Mao SC; Morgan JB; Jekabsons MB; Zhou YD; Nagle DG J Nat Prod; 2008 Nov; 71(11):1854-60. PubMed ID: 18989978 [TBL] [Abstract][Full Text] [Related]
11. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells. Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Rao SV; Joshi KS Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):15-27. PubMed ID: 22083267 [TBL] [Abstract][Full Text] [Related]
12. Apigenin down-regulates the hypoxia response genes: HIF-1α, GLUT-1, and VEGF in human pancreatic cancer cells. Melstrom LG; Salabat MR; Ding XZ; Strouch MJ; Grippo PJ; Mirzoeva S; Pelling JC; Bentrem DJ J Surg Res; 2011 May; 167(2):173-81. PubMed ID: 21227456 [TBL] [Abstract][Full Text] [Related]
13. Steppogenin suppresses tumor growth and sprouting angiogenesis through inhibition of HIF-1α in tumors and DLL4 activity in the endothelium. Cha S; Kim HG; Jang H; Lee J; Chao T; Baek NI; Song IS; Lee YM Phytomedicine; 2023 Jan; 108():154513. PubMed ID: 36332389 [TBL] [Abstract][Full Text] [Related]
16. Basic FGF augments hypoxia induced HIF-1-alpha expression and VEGF release in T47D breast cancer cells. Shi YH; Bingle L; Gong LH; Wang YX; Corke KP; Fang WG Pathology; 2007 Aug; 39(4):396-400. PubMed ID: 17676480 [TBL] [Abstract][Full Text] [Related]
17. Laurenditerpenol, a new diterpene from the tropical marine alga Laurenciaintricata that potently inhibits HIF-1 mediated hypoxic signaling in breast tumor cells. Mohammed KA; Hossain CF; Zhang L; Bruick RK; Zhou YD; Nagle DG J Nat Prod; 2004 Dec; 67(12):2002-7. PubMed ID: 15620241 [TBL] [Abstract][Full Text] [Related]
18. Regulation of glucose transporter protein-1 and vascular endothelial growth factor by hypoxia inducible factor 1α under hypoxic conditions in Hep-2 human cells. Xu O; Li X; Qu Y; Liu S; An J; Wang M; Sun Q; Zhang W; Lu X; Pi L; Zhang M; Shen Y Mol Med Rep; 2012 Dec; 6(6):1418-22. PubMed ID: 22971798 [TBL] [Abstract][Full Text] [Related]
19. Effects of geldanamycin on HIF-1alpha mediated angiogenesis and invasion in prostate cancer cells. Alqawi O; Moghaddas M; Singh G Prostate Cancer Prostatic Dis; 2006; 9(2):126-35. PubMed ID: 16432534 [TBL] [Abstract][Full Text] [Related]
20. Identification of a novel small-molecule inhibitor of the hypoxia-inducible factor 1 pathway. Tan C; de Noronha RG; Roecker AJ; Pyrzynska B; Khwaja F; Zhang Z; Zhang H; Teng Q; Nicholson AC; Giannakakou P; Zhou W; Olson JJ; Pereira MM; Nicolaou KC; Van Meir EG Cancer Res; 2005 Jan; 65(2):605-12. PubMed ID: 15695405 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]